This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.
N Benowitz (1999). Nicotine addiction. Primary Care 26, 611–631.
M Bergstrom , A Nordberg , E Lunell , G Aton , (1995). Regional disposition of inhaled 11C-vapor in the human airways as visualized by positron emission tomography. Clinical Pharmacological Therapy 57, 309–317.
A Brody , M Mandelkern , M Costello , A Abrams , (2009). Brain nicotinic cetylcholine receptor occupancy: effect of smoking a denicotinized cigarette. International Journal of Neuropsychopharmacology 12, 305–316.
A Brody , M Mandelkern , E London , R Olmstead , (2006). Cigarette smoking saturates brain alpha 4 beta 2 nicotinic acetylcholine receptors. Archives of General Psychiatry 63, 907–915.
B Caldwell , S Dickson , C Burgess , R Siebers , (2009). A pilot study of nicotine delivery to smokers from a metered-dose inhaler. Nicotine and Tobacco Research 11, 342–347.
V Cunningham , E Rabiner , M Slifstein , M Laruelle , RN Gunn (2010). Measuring drug occupancy in the absence of a reference region: the Lassen plot re-visited. Journal of Cerebral Blood Flow and Metabolism 30, 46–50.
M Epping-Jordan , M Picciotto , J Changeux , EM Pich (1999). Assessment of nicotinic acetylcholine receptor subunit contributions to nicotine self-administration in mutant mice. Psychopharmacology 147, 25–26.
I Esterlis , K Cosgrove , (2010). Quantification of smoking induced occupancy of β2-nicotinic acetylcholine receptors: estimation of nondisplaceable binding. Journal of Nuclear Medicine 51, 1226–1233.
S Gourlay , N Benowitz (1997). Arteriovenous differences in plasma concentration of nicotine and catecholamines and related cardiovascular effects after smoking, nicotine nasal spray and intravenous nicotine. Clinical Pharmacological Therapy 62, 453–463.
D Hatsukami , J Hughes , R Pickens , D Svikis (1984). Tobacco withdrawal symptoms: An experimental analysis. Psychopharmacology 84, 231–236.
T Heatherton , L Kozlowski , R Frecker , K Fagerstrom (1991). The Fagerstrom test for nicotine dependence: a revision of the Fagerstrom tolerance questionnaire. British Journal of Addiction 86, 1119–1127.
J Henningfield , J Stapletom , N Benowitz , R Grayson , (1993). Higher levels of nicotine in arterial than in venous blood after cigarette smoking. Drug and Alcohol Dependence 33, 23–29.
R Innis , V Cunningham , J Delforge , M Fujita , (2007). Consensus nomenclature for in vivo imaging of reversibly binding radioligands. Journal of Cerebral Blood Flow and Metabolism 27, 1533–1539.
A Kahlil , S Steyn , N Castagnoli (2000). Isolation and characterization of monoamine oxidase inhibitor from tobacco leaves. Chemistry Research and Toxicology 13, 31–35.
E Lunell , M Bergström , G Antoni , B Långström , A Nordberg (1996). Nicotine deposition and body distribution from a nicotine inhaler and a cigarette studied with positron emission tomography. Clinical Pharmacology and Therapeutics 59, 593–594.
H Mansvelder , J Keath , D McGehee (2002). Synaptic mechanisms underlie nicotine induced excitability of brain reward areas. Neuron 33, 905–919.
U Maskos , B Molles , S Pons , M Besson , (2005). Nicotine reinforcement and cognition restored by targeted expression of nicotinic receptors. Nature 436, 103–107.
D Meyers , J Neuberger (2008). Cardiovascular effect of bans on smoking in public places. American Journal of Cardiology 102, 1421–1424.
D Monchuk , M Rousu , J Shogren , J Nonnemaker , (2007). Decomposing the value of cigarettes using experimental auctions. Nicotine and Tobacco Research 9, 93–99.
E Nestler (2005). Is there a common molecular pathway for addiction? Nature Neuroscience. 8, 1445–1449.
M Rice , S Cragg (2004). Nicotine amplifies reward-related dopamine signals in striatum. Nature Neuroscience 7, 583–584.
J Roll , S Higgins , G Badger (1996). An experimental comparison of three different schedules of reinforcement of drug abstinence using cigarette smoking as an exemplar. Journal of Applied Behavior Analysis 29, 495–504.
J Rose , F Behm (2004). Extinguishing the rewarding value of smoke cues: Pharmacological and behavioral treatments. Nicotine and Tobacco Research 6, 523–532.
N Schneider , C Cortner , J Gould , MKR Olmstead (2008). Comparison of craving and withdrawal among four combination nicotine treatments. Human Psychopharmacology 23, 513–517.
N Schneider , R Olmstead , M Franzon , E Lunell (2001). The Nicotine Inhaler: Clinical pharmacokinetics and comparison with other nicotine treatments. Clinical Pharmacokinetics 40, 661–684.
N Schneider , S Terrace , M Koury , S Patel , (2005). Comparison of three nicotine treatments: initial reactions and preferences with guided use. Psychopharmacology (Berlin) 182, 545–550.
M Sofuoglu , M Mouratidis , S Yoo , KCT Kosten (2005). Effects of tiagabine in combination with intravenous nicotine in overnight abstinent smokers. Psychopharmacology (Berlin) 181, 504–510.
J Staley , S Krishnan-Sarin , K Cosgrove , E Krantzler , (2006). Human tobacco smokers in early abstinence have higher levels of beta2-nicotinic acetylcholine receptors than nonsmokers. Journal of Neuroscience 26, 8707–8714.
M Stitzer , G Bigelow (1985). Contingent reinforcement for reduced breath carbon monoxide levels: target-specific effects on cigarette smoking. Addictive Behavior 10, 345–349.
M Stitzer , C Rand , G Bigelow , A Mead (1986). Contingent payment procedures for smoking reduction and cessation. Journal of Applied Behavioral Analysis 19, 197–202.
I Stolerman , M Shoaib (1991). The neurobiology of tobacco addiction. Trends in Pharmacological Science 12, 467–473.
S Tiffany , D Drobes (1991). The development and initial validation of a questionnaire on smoking urges. British Journal of Addictions 86, 1467–1476.
P Tønnesen (2009). Smoking cessation: How compelling is the evidence? A review. Health Policy 91 (Suppl. 1), S15–S25.
D Vaupel , A Mukhin , A Kimes , A Horti , (1998). In vivo studies with [125I]5-IA 85380, a nicotinic acetylcholine receptor radioligand. NeuroReport 9, 2311–2317.
H Zhang , D Sulzer (2004). Frequency-dependent modulation of dopamine release by nicotine. Nature Neuroscience 7, 581–582.
S Zoghbi , G Tamagnan , M Fujita , R Baldwin , (2001). Measurement of plasma metabolites of (S)-5-[123I]iodo-3-(2-azetidinylmethoxy) pyridine (5-IA-85380), a nicotinic acetylcholine receptor imaging agent, in non-human primates. Nuclear Medicine and Biology 28, 91–96.